

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.17247265 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.17247265 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.99091208 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.99091208 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.38554335 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.16278283 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 5.93114531 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.81559511 |
| 9 | kynurenine metabolic process (GO:0070189) | 5.73994204 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.72248362 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.72248362 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.72248362 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.48545891 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.44641835 |
| 15 | urea metabolic process (GO:0019627) | 5.43634665 |
| 16 | urea cycle (GO:0000050) | 5.43634665 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.42980677 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42892783 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.29665950 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.26663489 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22969798 |
| 22 | protein carboxylation (GO:0018214) | 5.10813020 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.10813020 |
| 24 | cysteine metabolic process (GO:0006534) | 5.06312862 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.02391965 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.02021719 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.01276010 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.97678555 |
| 29 | bile acid metabolic process (GO:0008206) | 4.79304622 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.76764043 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.71474471 |
| 32 | regulation of complement activation (GO:0030449) | 4.68379054 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.67736826 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.67704868 |
| 35 | lysine metabolic process (GO:0006553) | 4.66433716 |
| 36 | lysine catabolic process (GO:0006554) | 4.66433716 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.65592726 |
| 38 | ethanol metabolic process (GO:0006067) | 4.60563411 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.58602666 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.51338553 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43339347 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.43339347 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.43339347 |
| 44 | negative regulation of cholesterol transport (GO:0032375) | 4.42009507 |
| 45 | negative regulation of sterol transport (GO:0032372) | 4.42009507 |
| 46 | drug metabolic process (GO:0017144) | 4.40085150 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.38852993 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.38852993 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.38336673 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.38040480 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.34763198 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.34000728 |
| 53 | glucuronate metabolic process (GO:0019585) | 4.30552282 |
| 54 | uronic acid metabolic process (GO:0006063) | 4.30552282 |
| 55 | oxidative demethylation (GO:0070989) | 4.27191364 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.25347143 |
| 57 | ethanol oxidation (GO:0006069) | 4.20910398 |
| 58 | phospholipid efflux (GO:0033700) | 4.18342357 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.10969377 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.09530501 |
| 61 | glycine metabolic process (GO:0006544) | 4.09017466 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.08565848 |
| 63 | cellular modified amino acid catabolic process (GO:0042219) | 4.08514480 |
| 64 | phenylpropanoid metabolic process (GO:0009698) | 4.08078747 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.04663086 |
| 66 | glutamate metabolic process (GO:0006536) | 4.01501727 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 3.93489072 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 3.91512965 |
| 69 | cholesterol efflux (GO:0033344) | 3.90445429 |
| 70 | cellular glucuronidation (GO:0052695) | 3.88292162 |
| 71 | S-adenosylmethionine metabolic process (GO:0046500) | 3.87454676 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 3.86399485 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 3.86088175 |
| 74 | drug catabolic process (GO:0042737) | 3.84918019 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.79298941 |
| 76 | amine catabolic process (GO:0009310) | 3.78746544 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 3.78746544 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 3.77747942 |
| 79 | arginine metabolic process (GO:0006525) | 3.74864268 |
| 80 | intestinal cholesterol absorption (GO:0030299) | 3.74094571 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.71670850 |
| 82 | phospholipid homeostasis (GO:0055091) | 3.70751922 |
| 83 | ketone body metabolic process (GO:1902224) | 3.67736731 |
| 84 | behavioral response to nicotine (GO:0035095) | 3.67479226 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.67266785 |
| 86 | negative regulation of protein activation cascade (GO:2000258) | 3.65460120 |
| 87 | fibrinolysis (GO:0042730) | 3.64329638 |
| 88 | complement activation, classical pathway (GO:0006958) | 3.63895707 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63251426 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63251426 |
| 91 | negative regulation of lipase activity (GO:0060192) | 3.62899018 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.62761938 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.62606888 |
| 94 | organic acid catabolic process (GO:0016054) | 3.62157948 |
| 95 | carboxylic acid catabolic process (GO:0046395) | 3.62157948 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.61356454 |
| 97 | 2-oxoglutarate metabolic process (GO:0006103) | 3.60812965 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 3.59471108 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.58010799 |
| 100 | protein activation cascade (GO:0072376) | 3.54384303 |
| 101 | complement activation (GO:0006956) | 3.54343639 |
| 102 | nucleobase catabolic process (GO:0046113) | 3.53701748 |
| 103 | flavonoid metabolic process (GO:0009812) | 3.52630268 |
| 104 | sterol homeostasis (GO:0055092) | 3.52589145 |
| 105 | cytolysis (GO:0019835) | 3.46953426 |
| 106 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46526971 |
| 107 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.45480291 |
| 108 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.44158843 |
| 109 | valine metabolic process (GO:0006573) | 3.42899424 |
| 110 | drug transmembrane transport (GO:0006855) | 3.42803519 |
| 111 | fatty acid oxidation (GO:0019395) | 3.42552407 |
| 112 | cofactor catabolic process (GO:0051187) | 3.40138868 |
| 113 | exogenous drug catabolic process (GO:0042738) | 3.39850923 |
| 114 | acute-phase response (GO:0006953) | 3.39609545 |
| 115 | macroautophagy (GO:0016236) | 3.38971674 |
| 116 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.24226975 |
| 117 | alkaloid metabolic process (GO:0009820) | 3.23950271 |
| 118 | negative regulation of complement activation (GO:0045916) | 3.23581071 |
| 119 | primary alcohol catabolic process (GO:0034310) | 3.22131925 |
| 120 | axonemal dynein complex assembly (GO:0070286) | 3.08413190 |
| 121 | intestinal absorption (GO:0050892) | 3.05532810 |
| 122 | positive regulation of glycolytic process (GO:0045821) | 2.98590517 |
| 123 | regulation of glucokinase activity (GO:0033131) | 2.96260454 |
| 124 | regulation of hexokinase activity (GO:1903299) | 2.96260454 |
| 125 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.92134035 |
| 126 | xenobiotic metabolic process (GO:0006805) | 2.84923987 |
| 127 | primary alcohol metabolic process (GO:0034308) | 2.79458576 |
| 128 | heme transport (GO:0015886) | 2.70535648 |
| 129 | fucose catabolic process (GO:0019317) | 2.68860295 |
| 130 | L-fucose metabolic process (GO:0042354) | 2.68860295 |
| 131 | L-fucose catabolic process (GO:0042355) | 2.68860295 |
| 132 | androgen metabolic process (GO:0008209) | 2.66858232 |
| 133 | nephron tubule morphogenesis (GO:0072078) | 2.60174777 |
| 134 | nephron epithelium morphogenesis (GO:0072088) | 2.60174777 |
| 135 | positive regulation of fatty acid oxidation (GO:0046321) | 2.59967715 |
| 136 | epithelial cilium movement (GO:0003351) | 2.59281629 |
| 137 | regulation of plasminogen activation (GO:0010755) | 2.56599840 |
| 138 | opsonization (GO:0008228) | 2.55375388 |
| 139 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.55181778 |
| 140 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.55181778 |
| 141 | peptidyl-glutamic acid modification (GO:0018200) | 2.54489098 |
| 142 | negative regulation of humoral immune response (GO:0002921) | 2.53463053 |
| 143 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.52216024 |
| 144 | sodium-independent organic anion transport (GO:0043252) | 2.51131048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.88018203 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.86703193 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.07814151 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.04651782 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.13057678 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.80213397 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.61300846 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87876765 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.52352385 |
| 10 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.49417212 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47560236 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.27712114 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25450430 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21316279 |
| 15 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.19272834 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14810407 |
| 17 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.12584405 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.11730703 |
| 19 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09232918 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.04559772 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03726095 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2459014 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.96908444 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94153603 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92124908 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.88075461 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.76796438 |
| 28 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.73302744 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.70096712 |
| 30 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67237476 |
| 31 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.67202734 |
| 32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63961168 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61803314 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60886363 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60385735 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56350444 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56165210 |
| 38 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.55880476 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49513854 |
| 40 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.49005268 |
| 41 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.48959949 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48852777 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48453835 |
| 44 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47329421 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46527338 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45521594 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44394847 |
| 48 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44073190 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36755431 |
| 50 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36638353 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34683669 |
| 52 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34420259 |
| 53 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34309952 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34100967 |
| 55 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32314607 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27787112 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25788188 |
| 58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25463906 |
| 59 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24694604 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23676151 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23293482 |
| 62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23227752 |
| 63 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.22944841 |
| 64 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22569064 |
| 65 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22519659 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20515573 |
| 67 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20515573 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20026660 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19406006 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17493177 |
| 71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17387166 |
| 72 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17141547 |
| 73 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16834020 |
| 74 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16797527 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16637260 |
| 76 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16431353 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16139815 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15407110 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15394313 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.15343660 |
| 81 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15120808 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14926330 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14514085 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13402715 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13199359 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.12480267 |
| 87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11637561 |
| 88 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09734429 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09579023 |
| 90 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09169140 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09091039 |
| 92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09056414 |
| 93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07948253 |
| 94 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.07802073 |
| 95 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.07723435 |
| 96 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07273052 |
| 97 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07273052 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05350769 |
| 99 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04964376 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04368329 |
| 101 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.04126131 |
| 102 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03791428 |
| 103 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03377971 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03128772 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01749314 |
| 106 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00979750 |
| 107 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00499922 |
| 108 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.00470603 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99753226 |
| 110 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98549972 |
| 111 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97663579 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93740164 |
| 113 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93540204 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93319334 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90598081 |
| 116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87857266 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85964916 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82897058 |
| 119 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80869470 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80157802 |
| 121 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79310177 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77348344 |
| 123 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75896188 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75541161 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75125604 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75044409 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74402613 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.74085711 |
| 129 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.73876919 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73511065 |
| 131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.73288166 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72409154 |
| 133 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.71368374 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70853998 |
| 135 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.70594391 |
| 136 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69572065 |
| 137 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.67744377 |
| 138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67626369 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67288495 |
| 140 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.66724460 |
| 141 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66331407 |
| 142 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64320037 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62596086 |
| 144 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.62180874 |
| 145 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61860254 |
| 146 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.61134437 |
| 147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60844250 |
| 148 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.60092508 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.59918618 |
| 150 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.57850230 |
| 151 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.56921664 |
| 152 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56381670 |
| 153 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.55400731 |
| 154 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55338263 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.54854136 |
| 156 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.54609855 |
| 157 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.54200049 |
| 158 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53839193 |
| 159 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53427752 |
| 160 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52743506 |
| 161 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.51982651 |
| 162 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.51936323 |
| 163 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.51723886 |
| 164 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.50288743 |
| 165 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.49511799 |
| 166 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48615874 |
| 167 | ATF3_27146783_Chip-Seq_COLON_Human | 0.48584645 |
| 168 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47729966 |
| 169 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.47648892 |
| 170 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.47648892 |
| 171 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47512051 |
| 172 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.47235985 |
| 173 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.47235985 |
| 174 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47233997 |
| 175 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47192855 |
| 176 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.46297133 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.81945527 |
| 2 | MP0005360_urolithiasis | 7.05775646 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15383091 |
| 4 | MP0005365_abnormal_bile_salt | 5.97727734 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.95716740 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.83539083 |
| 7 | MP0003252_abnormal_bile_duct | 3.82254195 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.49599905 |
| 9 | MP0009840_abnormal_foam_cell | 3.14839988 |
| 10 | MP0005083_abnormal_biliary_tract | 2.95200867 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.92158455 |
| 12 | MP0005332_abnormal_amino_acid | 2.55827479 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.40191407 |
| 14 | MP0003195_calcinosis | 2.39356716 |
| 15 | MP0000609_abnormal_liver_physiology | 2.19023766 |
| 16 | MP0003868_abnormal_feces_composition | 2.18392102 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.06674577 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.97599470 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.97175173 |
| 20 | MP0002909_abnormal_adrenal_gland | 1.88840507 |
| 21 | * MP0005319_abnormal_enzyme/_coenzyme | 1.81325357 |
| 22 | MP0002638_abnormal_pupillary_reflex | 1.62223396 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56583346 |
| 24 | MP0001764_abnormal_homeostasis | 1.55961444 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 1.51931947 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.49306921 |
| 27 | MP0010234_abnormal_vibrissa_follicle | 1.41919750 |
| 28 | * MP0009643_abnormal_urine_homeostasis | 1.40490484 |
| 29 | MP0002102_abnormal_ear_morphology | 1.39364328 |
| 30 | MP0009046_muscle_twitch | 1.38476971 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.38165419 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.37001614 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.34247616 |
| 34 | MP0003283_abnormal_digestive_organ | 1.31145821 |
| 35 | MP0009697_abnormal_copulation | 1.28561923 |
| 36 | MP0004147_increased_porphyrin_level | 1.28377623 |
| 37 | MP0010386_abnormal_urinary_bladder | 1.27207695 |
| 38 | MP0003890_abnormal_embryonic-extraembry | 1.25198826 |
| 39 | MP0000598_abnormal_liver_morphology | 1.23085136 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.23035503 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.20981223 |
| 42 | MP0005379_endocrine/exocrine_gland_phen | 1.16624819 |
| 43 | MP0000604_amyloidosis | 1.13400168 |
| 44 | MP0009745_abnormal_behavioral_response | 1.13194310 |
| 45 | MP0003186_abnormal_redox_activity | 1.11451175 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.10839644 |
| 47 | MP0005636_abnormal_mineral_homeostasis | 1.09513467 |
| 48 | MP0003011_delayed_dark_adaptation | 1.08190042 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.06485766 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 1.05928584 |
| 51 | MP0001502_abnormal_circadian_rhythm | 1.04465037 |
| 52 | MP0000427_abnormal_hair_cycle | 1.03492299 |
| 53 | MP0009764_decreased_sensitivity_to | 1.03124584 |
| 54 | MP0005647_abnormal_sex_gland | 1.02975943 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 1.02041430 |
| 56 | MP0004142_abnormal_muscle_tone | 0.99573555 |
| 57 | MP0005670_abnormal_white_adipose | 0.98417813 |
| 58 | MP0003122_maternal_imprinting | 0.96378852 |
| 59 | MP0009763_increased_sensitivity_to | 0.96295615 |
| 60 | MP0005451_abnormal_body_composition | 0.96238491 |
| 61 | MP0003300_gastrointestinal_ulcer | 0.95764667 |
| 62 | MP0004924_abnormal_behavior | 0.94841611 |
| 63 | MP0005386_behavior/neurological_phenoty | 0.94841611 |
| 64 | MP0004130_abnormal_muscle_cell | 0.94287769 |
| 65 | * MP0009642_abnormal_blood_homeostasis | 0.90050313 |
| 66 | MP0002168_other_aberrant_phenotype | 0.88779967 |
| 67 | * MP0008469_abnormal_protein_level | 0.88708432 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 0.86353610 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 0.86201098 |
| 70 | MP0002693_abnormal_pancreas_physiology | 0.85958420 |
| 71 | MP0004133_heterotaxia | 0.85857180 |
| 72 | MP0002163_abnormal_gland_morphology | 0.84170573 |
| 73 | MP0003632_abnormal_nervous_system | 0.83973444 |
| 74 | MP0002272_abnormal_nervous_system | 0.83727314 |
| 75 | MP0002557_abnormal_social/conspecific_i | 0.83684651 |
| 76 | MP0005408_hypopigmentation | 0.82901120 |
| 77 | MP0000383_abnormal_hair_follicle | 0.82041719 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 0.80868584 |
| 79 | MP0002254_reproductive_system_inflammat | 0.80758166 |
| 80 | MP0002064_seizures | 0.78243564 |
| 81 | MP0000566_synostosis | 0.77916930 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.77382273 |
| 83 | MP0004885_abnormal_endolymph | 0.75487022 |
| 84 | MP0001756_abnormal_urination | 0.75242469 |
| 85 | MP0008775_abnormal_heart_ventricle | 0.74985210 |
| 86 | MP0005084_abnormal_gallbladder_morpholo | 0.74837494 |
| 87 | MP0005376_homeostasis/metabolism_phenot | 0.74825577 |
| 88 | MP0002572_abnormal_emotion/affect_behav | 0.74754116 |
| 89 | MP0002876_abnormal_thyroid_physiology | 0.74479539 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.74296763 |
| 91 | MP0003879_abnormal_hair_cell | 0.73617492 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.73606894 |
| 93 | MP0005334_abnormal_fat_pad | 0.72840541 |
| 94 | MP0002938_white_spotting | 0.72823638 |
| 95 | MP0005253_abnormal_eye_physiology | 0.72810951 |
| 96 | MP0005409_darkened_coat_color | 0.71367109 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.70366258 |
| 98 | MP0005395_other_phenotype | 0.68407714 |
| 99 | MP0002009_preneoplasia | 0.65872979 |
| 100 | MP0002971_abnormal_brown_adipose | 0.65501482 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.64409123 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.64190790 |
| 103 | MP0003045_fibrosis | 0.62832441 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.61716559 |
| 105 | MP0001986_abnormal_taste_sensitivity | 0.61637620 |
| 106 | MP0003329_amyloid_beta_deposits | 0.61016981 |
| 107 | MP0001440_abnormal_grooming_behavior | 0.60707687 |
| 108 | MP0000778_abnormal_nervous_system | 0.60427658 |
| 109 | MP0003646_muscle_fatigue | 0.60379406 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.60019999 |
| 111 | MP0005535_abnormal_body_temperature | 0.59668969 |
| 112 | MP0005266_abnormal_metabolism | 0.58753595 |
| 113 | MP0002063_abnormal_learning/memory/cond | 0.58736606 |
| 114 | MP0003633_abnormal_nervous_system | 0.58512840 |
| 115 | MP0001970_abnormal_pain_threshold | 0.57703841 |
| 116 | MP0002733_abnormal_thermal_nociception | 0.57349506 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.56380534 |
| 118 | MP0001881_abnormal_mammary_gland | 0.55220826 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.54538852 |
| 120 | MP0005448_abnormal_energy_balance | 0.54380175 |
| 121 | MP0001873_stomach_inflammation | 0.54215099 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.53691713 |
| 123 | * MP0002136_abnormal_kidney_physiology | 0.52847466 |
| 124 | MP0001661_extended_life_span | 0.52677835 |
| 125 | MP0008873_increased_physiological_sensi | 0.50479234 |
| 126 | MP0003075_altered_response_to | 0.49757196 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.49404527 |
| 128 | MP0005166_decreased_susceptibility_to | 0.48555527 |
| 129 | MP0003953_abnormal_hormone_level | 0.47541597 |
| 130 | MP0008874_decreased_physiological_sensi | 0.47082017 |
| 131 | MP0009780_abnormal_chondrocyte_physiolo | 0.47072192 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.46953079 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.46609881 |
| 134 | MP0002928_abnormal_bile_duct | 0.45700550 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.45698460 |
| 136 | MP0001944_abnormal_pancreas_morphology | 0.45230112 |
| 137 | MP0001663_abnormal_digestive_system | 0.45190939 |
| 138 | MP0010155_abnormal_intestine_physiology | 0.45045803 |
| 139 | MP0000230_abnormal_systemic_arterial | 0.44672526 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.43802464 |
| 141 | MP0002166_altered_tumor_susceptibility | 0.43772494 |
| 142 | MP0001845_abnormal_inflammatory_respons | 0.42471777 |
| 143 | MP0003436_decreased_susceptibility_to | 0.42159715 |
| 144 | MP0003690_abnormal_glial_cell | 0.41606513 |
| 145 | MP0003724_increased_susceptibility_to | 0.41159278 |
| 146 | MP0000249_abnormal_blood_vessel | 0.40685047 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.40461129 |
| 148 | MP0008872_abnormal_physiological_respon | 0.40286097 |
| 149 | MP0004947_skin_inflammation | 0.40147957 |
| 150 | MP0002822_catalepsy | 0.39255897 |
| 151 | MP0004043_abnormal_pH_regulation | 0.37368272 |
| 152 | MP0005187_abnormal_penis_morphology | 0.36897054 |
| 153 | MP0005381_digestive/alimentary_phenotyp | 0.36856750 |
| 154 | MP0009053_abnormal_anal_canal | 0.36244250 |
| 155 | MP0009115_abnormal_fat_cell | 0.34830797 |
| 156 | MP0002970_abnormal_white_adipose | 0.33942000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.09701196 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.99622006 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.91737873 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.41117094 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.98763135 |
| 6 | Xanthomatosis (HP:0000991) | 5.89491964 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.81941704 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.02896709 |
| 9 | Complement deficiency (HP:0004431) | 4.95675421 |
| 10 | Hyperammonemia (HP:0001987) | 4.52305581 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47037292 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.38435838 |
| 13 | Ketosis (HP:0001946) | 4.32858584 |
| 14 | Fat malabsorption (HP:0002630) | 4.20375971 |
| 15 | Joint hemorrhage (HP:0005261) | 4.20323903 |
| 16 | Epidermoid cyst (HP:0200040) | 4.12630227 |
| 17 | Hyperglycinemia (HP:0002154) | 4.09882626 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99496375 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99418741 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.94005730 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93916327 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.88966082 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.87655428 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.75529056 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.70828252 |
| 26 | Hyperventilation (HP:0002883) | 3.70275560 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.61798465 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.60459159 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.60459159 |
| 30 | Hyperglycinuria (HP:0003108) | 3.59665217 |
| 31 | Abnormality of complement system (HP:0005339) | 3.59602514 |
| 32 | Decreased circulating renin level (HP:0003351) | 3.49153356 |
| 33 | Fair hair (HP:0002286) | 3.43212908 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42739313 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.30612515 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.29984055 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29459818 |
| 38 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.28510175 |
| 39 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.28510175 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26892972 |
| 41 | Ketoacidosis (HP:0001993) | 3.24210087 |
| 42 | Steatorrhea (HP:0002570) | 3.21316537 |
| 43 | Absent/shortened dynein arms (HP:0200106) | 3.12693764 |
| 44 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.12693764 |
| 45 | Spontaneous abortion (HP:0005268) | 3.06296056 |
| 46 | Delayed CNS myelination (HP:0002188) | 3.00202340 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.90828420 |
| 48 | Tubular atrophy (HP:0000092) | 2.90651872 |
| 49 | Nephronophthisis (HP:0000090) | 2.90212747 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.89963135 |
| 51 | Pancreatic cysts (HP:0001737) | 2.88840461 |
| 52 | Myocardial infarction (HP:0001658) | 2.84186855 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.83256740 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.80191374 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.80191374 |
| 56 | Chronic hepatic failure (HP:0100626) | 2.76043020 |
| 57 | Skin nodule (HP:0200036) | 2.75815050 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.75629209 |
| 59 | Arthropathy (HP:0003040) | 2.73876012 |
| 60 | Abnormality of renin-angiotensin system (HP:0000847) | 2.73347841 |
| 61 | Metabolic acidosis (HP:0001942) | 2.71423191 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.70214794 |
| 63 | Acanthocytosis (HP:0001927) | 2.65069148 |
| 64 | Generalized hypopigmentation of hair (HP:0011358) | 2.63945607 |
| 65 | Abnormal ciliary motility (HP:0012262) | 2.63161258 |
| 66 | Abnormality of the renal cortex (HP:0011035) | 2.62101500 |
| 67 | Hypothermia (HP:0002045) | 2.58186952 |
| 68 | Spastic diplegia (HP:0001264) | 2.56036345 |
| 69 | Abnormality of the renal medulla (HP:0100957) | 2.55197407 |
| 70 | Hyperactive renin-angiotensin system (HP:0000841) | 2.52863175 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 2.52251600 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.52251600 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.51560872 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49454201 |
| 75 | Abnormality of alanine metabolism (HP:0010916) | 2.49454201 |
| 76 | Hyperalaninemia (HP:0003348) | 2.49454201 |
| 77 | Congenital stationary night blindness (HP:0007642) | 2.49282841 |
| 78 | Gout (HP:0001997) | 2.48763454 |
| 79 | Rhinitis (HP:0012384) | 2.48078885 |
| 80 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.43654847 |
| 81 | Vascular calcification (HP:0004934) | 2.42532051 |
| 82 | Type II lissencephaly (HP:0007260) | 2.41477041 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.39327281 |
| 84 | Lethargy (HP:0001254) | 2.39043178 |
| 85 | Metabolic alkalosis (HP:0200114) | 2.38074407 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.36552242 |
| 87 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.35339199 |
| 88 | Large for gestational age (HP:0001520) | 2.35317608 |
| 89 | True hermaphroditism (HP:0010459) | 2.34192333 |
| 90 | Cholecystitis (HP:0001082) | 2.33877333 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.33877333 |
| 92 | Late onset (HP:0003584) | 2.33791488 |
| 93 | Esophageal varix (HP:0002040) | 2.33771263 |
| 94 | Pancreatitis (HP:0001733) | 2.33513804 |
| 95 | Cholelithiasis (HP:0001081) | 2.33092041 |
| 96 | Malnutrition (HP:0004395) | 2.31623733 |
| 97 | Blue irides (HP:0000635) | 2.29678782 |
| 98 | Mitral stenosis (HP:0001718) | 2.29146829 |
| 99 | Gingival bleeding (HP:0000225) | 2.29113322 |
| 100 | Irritability (HP:0000737) | 2.28544663 |
| 101 | Abnormality of chloride homeostasis (HP:0011422) | 2.27761796 |
| 102 | Neonatal onset (HP:0003623) | 2.27735973 |
| 103 | Menorrhagia (HP:0000132) | 2.24709132 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.23882208 |
| 105 | Polydipsia (HP:0001959) | 2.18374055 |
| 106 | Abnormal drinking behavior (HP:0030082) | 2.18374055 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.17096140 |
| 108 | Abnormality of vitamin metabolism (HP:0100508) | 2.14440530 |
| 109 | Brushfield spots (HP:0001088) | 2.14329709 |
| 110 | Amyloidosis (HP:0011034) | 2.13777490 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 2.13716272 |
| 112 | Hemorrhage of the eye (HP:0011885) | 2.13653590 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.13166381 |
| 114 | Glomerulonephritis (HP:0000099) | 2.11493983 |
| 115 | Cystic liver disease (HP:0006706) | 2.10184247 |
| 116 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.10043944 |
| 117 | Chorioretinal atrophy (HP:0000533) | 2.08906497 |
| 118 | Nephritis (HP:0000123) | 2.07157037 |
| 119 | Cerebral edema (HP:0002181) | 2.06852170 |
| 120 | Thrombophlebitis (HP:0004418) | 2.06524966 |
| 121 | Broad-based gait (HP:0002136) | 2.04015379 |
| 122 | Poikilocytosis (HP:0004447) | 2.02820692 |
| 123 | Abnormal biliary tract physiology (HP:0012439) | 2.02069687 |
| 124 | Bile duct proliferation (HP:0001408) | 2.02069687 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 2.01899157 |
| 126 | Hyperaldosteronism (HP:0000859) | 1.99892102 |
| 127 | Alkalosis (HP:0001948) | 1.96887704 |
| 128 | Abnormality of the gallbladder (HP:0005264) | 1.96030054 |
| 129 | Abnormality of potassium homeostasis (HP:0011042) | 1.94805492 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.93877184 |
| 131 | Vomiting (HP:0002013) | 1.92831019 |
| 132 | Hypokalemia (HP:0002900) | 1.91091755 |
| 133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89504427 |
| 134 | Widely spaced teeth (HP:0000687) | 1.89211850 |
| 135 | EEG with generalized epileptiform discharges (HP:0011198) | 1.89197292 |
| 136 | Hyperkalemia (HP:0002153) | 1.89158836 |
| 137 | Death in childhood (HP:0003819) | 1.88513767 |
| 138 | Hydroxyprolinuria (HP:0003080) | 1.86507911 |
| 139 | Abnormality of proline metabolism (HP:0010907) | 1.86507911 |
| 140 | Abnormality of iron homeostasis (HP:0011031) | 1.85710515 |
| 141 | Elevated hepatic transaminases (HP:0002910) | 1.85119142 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84581479 |
| 143 | Epileptiform EEG discharges (HP:0011182) | 1.82895807 |
| 144 | Symptomatic seizures (HP:0011145) | 1.82818306 |
| 145 | Tubulointerstitial fibrosis (HP:0005576) | 1.82377889 |
| 146 | Furrowed tongue (HP:0000221) | 1.82066247 |
| 147 | Hypsarrhythmia (HP:0002521) | 1.80882489 |
| 148 | Hyperglycemia (HP:0003074) | 1.80795935 |
| 149 | Increased mean platelet volume (HP:0011877) | 1.78925785 |
| 150 | Pheochromocytoma (HP:0002666) | 1.76376976 |
| 151 | Opisthotonus (HP:0002179) | 1.76299377 |
| 152 | Lissencephaly (HP:0001339) | 1.75413280 |
| 153 | Abnormality of the vitreous humor (HP:0004327) | 1.75164826 |
| 154 | Enlarged kidneys (HP:0000105) | 1.74818879 |
| 155 | Rickets (HP:0002748) | 1.74657224 |
| 156 | Medial flaring of the eyebrow (HP:0010747) | 1.74605063 |
| 157 | Stroke (HP:0001297) | 1.74442352 |
| 158 | Inability to walk (HP:0002540) | 1.72307553 |
| 159 | Abnormal pancreas size (HP:0012094) | 1.71727164 |
| 160 | Tubulointerstitial abnormality (HP:0001969) | 1.71454175 |
| 161 | Reticulocytosis (HP:0001923) | 1.69415945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.70461276 |
| 2 | ERN1 | 5.07721775 |
| 3 | SIK1 | 4.13132204 |
| 4 | FGFR4 | 3.44597463 |
| 5 | ACVR1B | 3.36069154 |
| 6 | TAOK3 | 3.26567715 |
| 7 | PKN2 | 3.20543712 |
| 8 | TRIB3 | 3.10457438 |
| 9 | WNK4 | 2.93686220 |
| 10 | CASK | 2.75044227 |
| 11 | INSRR | 2.65811934 |
| 12 | CAMKK2 | 2.56466993 |
| 13 | FLT3 | 2.53804161 |
| 14 | FRK | 2.49417369 |
| 15 | PNCK | 2.20744491 |
| 16 | ADRBK2 | 2.19356614 |
| 17 | BMPR1B | 2.16366513 |
| 18 | PTK6 | 2.05735603 |
| 19 | MST1R | 1.76306070 |
| 20 | MAP3K4 | 1.76124606 |
| 21 | MAP2K4 | 1.74226126 |
| 22 | ERBB4 | 1.68523950 |
| 23 | PIK3CG | 1.67739409 |
| 24 | WNK3 | 1.67224099 |
| 25 | KDR | 1.64020934 |
| 26 | PHKG2 | 1.63540181 |
| 27 | PHKG1 | 1.63540181 |
| 28 | MAPK11 | 1.58882303 |
| 29 | TLK1 | 1.56432101 |
| 30 | CAMK1G | 1.55139403 |
| 31 | TYK2 | 1.54677939 |
| 32 | MAP3K10 | 1.54347173 |
| 33 | LMTK2 | 1.48488125 |
| 34 | LATS1 | 1.42447848 |
| 35 | NTRK3 | 1.40164298 |
| 36 | AKT3 | 1.37592859 |
| 37 | MARK1 | 1.35237130 |
| 38 | MAP3K7 | 1.35201272 |
| 39 | RIPK1 | 1.33059945 |
| 40 | GRK6 | 1.28101376 |
| 41 | PINK1 | 1.25140136 |
| 42 | TRPM7 | 1.22326843 |
| 43 | EPHA2 | 1.22252583 |
| 44 | TBK1 | 1.21012292 |
| 45 | TIE1 | 1.19594288 |
| 46 | BRSK2 | 1.14504076 |
| 47 | JAK2 | 1.14117603 |
| 48 | MAP2K3 | 1.14092677 |
| 49 | STK38L | 1.11838121 |
| 50 | MKNK2 | 1.10621778 |
| 51 | EEF2K | 1.08499374 |
| 52 | NEK9 | 1.06602034 |
| 53 | NLK | 1.06128944 |
| 54 | JAK1 | 1.02437905 |
| 55 | ZAK | 1.01835920 |
| 56 | DAPK2 | 1.01151226 |
| 57 | IRAK1 | 0.99652185 |
| 58 | SCYL2 | 0.99321758 |
| 59 | PRKAA2 | 0.98580871 |
| 60 | TGFBR2 | 0.94982263 |
| 61 | ERBB3 | 0.94948800 |
| 62 | PIK3CA | 0.94893012 |
| 63 | STK3 | 0.94485995 |
| 64 | LRRK2 | 0.90384569 |
| 65 | MAP4K2 | 0.90074114 |
| 66 | RET | 0.89592840 |
| 67 | MAPK13 | 0.88860111 |
| 68 | EPHB1 | 0.86540359 |
| 69 | MAP4K1 | 0.86486011 |
| 70 | ERBB2 | 0.84789070 |
| 71 | FER | 0.84450385 |
| 72 | EPHA3 | 0.81117506 |
| 73 | STK39 | 0.80555932 |
| 74 | MYLK | 0.79891956 |
| 75 | SIK2 | 0.77033714 |
| 76 | PTK2 | 0.76851541 |
| 77 | CDK6 | 0.76114579 |
| 78 | SGK2 | 0.75778142 |
| 79 | WNK1 | 0.75240660 |
| 80 | CSF1R | 0.73956484 |
| 81 | ADRBK1 | 0.73902361 |
| 82 | MAP3K11 | 0.73086832 |
| 83 | PRKCE | 0.72376477 |
| 84 | MET | 0.72045388 |
| 85 | MAP2K6 | 0.70761689 |
| 86 | MAP3K2 | 0.69048027 |
| 87 | CAMK1D | 0.68589757 |
| 88 | MAPK4 | 0.67649634 |
| 89 | PTK2B | 0.66556493 |
| 90 | ABL2 | 0.65318445 |
| 91 | IKBKE | 0.64570157 |
| 92 | SGK223 | 0.63859309 |
| 93 | SGK494 | 0.63859309 |
| 94 | MAP2K2 | 0.63300032 |
| 95 | MAP2K1 | 0.62411996 |
| 96 | PRKG2 | 0.62226373 |
| 97 | PRKAA1 | 0.62127921 |
| 98 | CAMK4 | 0.61974415 |
| 99 | PRKCG | 0.61627288 |
| 100 | MAP3K1 | 0.61292427 |
| 101 | PDPK1 | 0.59994813 |
| 102 | PDGFRB | 0.59072985 |
| 103 | MAP2K7 | 0.57107370 |
| 104 | MAP3K3 | 0.56558935 |
| 105 | MAPKAPK3 | 0.56542042 |
| 106 | STK38 | 0.55985208 |
| 107 | JAK3 | 0.54529528 |
| 108 | CSK | 0.53371069 |
| 109 | PRKACG | 0.52466596 |
| 110 | MAPKAPK5 | 0.52192283 |
| 111 | KSR2 | 0.51859784 |
| 112 | ZAP70 | 0.51838000 |
| 113 | HIPK2 | 0.51553067 |
| 114 | MELK | 0.51444301 |
| 115 | BCR | 0.51375825 |
| 116 | PDK1 | 0.50158687 |
| 117 | STK11 | 0.49980098 |
| 118 | PRKCZ | 0.49813785 |
| 119 | MAPK12 | 0.47824759 |
| 120 | TGFBR1 | 0.47223530 |
| 121 | MAP3K6 | 0.46347405 |
| 122 | TNIK | 0.46305236 |
| 123 | GSK3A | 0.45630660 |
| 124 | ICK | 0.45247505 |
| 125 | KIT | 0.44985089 |
| 126 | FGFR3 | 0.44811186 |
| 127 | SGK3 | 0.44541573 |
| 128 | DYRK1B | 0.44172323 |
| 129 | CAMK2A | 0.43674432 |
| 130 | CAMKK1 | 0.43656653 |
| 131 | FGFR2 | 0.43559944 |
| 132 | RPS6KA5 | 0.43221391 |
| 133 | PDGFRA | 0.42467698 |
| 134 | STK24 | 0.41651485 |
| 135 | TAOK1 | 0.41596550 |
| 136 | NUAK1 | 0.41094750 |
| 137 | CSNK1G1 | 0.40669438 |
| 138 | SGK1 | 0.40409207 |
| 139 | MKNK1 | 0.39715294 |
| 140 | CSNK1E | 0.39497628 |
| 141 | MAP3K9 | 0.39425627 |
| 142 | CAMK2G | 0.36925778 |
| 143 | MTOR | 0.36504723 |
| 144 | MAP3K5 | 0.35754780 |
| 145 | TNK2 | 0.35175855 |
| 146 | OXSR1 | 0.34286752 |
| 147 | IGF1R | 0.34223425 |
| 148 | CAMK2D | 0.33636490 |
| 149 | EGFR | 0.32820967 |
| 150 | PRKCQ | 0.32289606 |
| 151 | PRKD1 | 0.29426752 |
| 152 | MAPK15 | 0.28265190 |
| 153 | ITK | 0.26662814 |
| 154 | CDK4 | 0.25278844 |
| 155 | GRK1 | 0.25275373 |
| 156 | PAK3 | 0.24917733 |
| 157 | BTK | 0.24531095 |
| 158 | PAK2 | 0.24192991 |
| 159 | MAP3K13 | 0.22740206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37649516 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65914874 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39553351 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36248213 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.08770055 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73966061 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.62387443 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61062078 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60692094 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53501769 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48750465 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35755243 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22193476 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07451368 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03787936 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99773854 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.98441224 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94809367 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87296512 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83033757 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81964866 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79633977 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.76364994 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72602806 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70042185 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69622587 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67305132 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67295437 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66970043 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66519150 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.62971882 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51909776 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47815110 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45558832 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44831549 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41722151 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41657643 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34683354 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34160577 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31529515 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31412053 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29966207 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.27931332 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.26678391 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25167528 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22971941 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20182723 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.08602939 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05186660 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04021743 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.99576137 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96975050 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91487957 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88047268 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87767724 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.87506193 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.85560626 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.83320590 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79197048 |
| 60 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77782404 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77504735 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76945200 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76926340 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72002445 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71527743 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67082736 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.65927033 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65621516 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64458632 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63190010 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62553576 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56821297 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56695337 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55437591 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54934815 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49651314 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46232023 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45712042 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 0.44292314 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.42574107 |
| 81 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.42155652 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42115557 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37180905 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36422826 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35704812 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.34316449 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.34127857 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30566089 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.29764055 |
| 90 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.28271894 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.26437190 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24930072 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22450997 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21027216 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.20989533 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20649129 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20580138 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19312811 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.18642559 |
| 100 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.18564673 |
| 101 | Taste transduction_Homo sapiens_hsa04742 | 0.17096185 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16634666 |
| 103 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.15665256 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.15610455 |
| 105 | Long-term depression_Homo sapiens_hsa04730 | 0.15081664 |
| 106 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.14739652 |
| 107 | Salivary secretion_Homo sapiens_hsa04970 | 0.14411899 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11990289 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09539077 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08498863 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06388898 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.04383140 |
| 113 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03477130 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.03167944 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02489628 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1657839 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | -0.1536485 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1532212 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | -0.1393605 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1382941 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1283521 |
| 122 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1239858 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1097864 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | -0.0892638 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0814801 |
| 126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0780922 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | -0.0518233 |
| 128 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0231580 |
| 129 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0230846 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0147315 |

